<i>In vitro</i> activities of aztreonam/nacubactam and cefepime/nacubactam against a global collection of molecularly characterized Enterobacterales isolates carrying carbapenemases: a global antimicrobial resistance surveillance study from 2021 to 2023. [PDF]
Estabrook M +3 more
europepmc +1 more source
Correction to "Sono-Triggered Cascade Lactate Depletion by Semiconducting Polymer Nanoreactors for Cuproptosis-Immunotherapy of Pancreatic Cancer". [PDF]
europepmc +1 more source
Management of KPC-Producing Klebsiella pneumoniae Infections [PDF]
Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae (KPC-KP) has become one of the most important contemporary pathogens, especially in endemic areas.To provide practical suggestion for physicians dealing with the management of KPC-KP infections in critically ill patients, based on expert opinions.PubMed search for relevant publications ...
Francesco Giuseppe De Rosa +2 more
exaly +13 more sources
Co-Resistance to Ceftazidime-Avibactam and Cefiderocol in Clinical Isolates Producing KPC Variants
Cefiderocol (FDC) and ceftazidime-avibactam (CZA) are among the latest generation of commercialized antibiotics against carbapenem-resistant Gram negatives.
Laurent Poirel +2 more
exaly +2 more sources
Emergence of KPC New Variants (KPC-16 and KPC-17) and Ongoing Outbreak in Southern Taiwan [PDF]
We first describe two novel variants of blaKPC, blaKPC-16 and blaKPC-17, which were identified in three Klebsiella pneumoniae isolates from a patient in Taiwan. KPC-16 and KPC-17 differed from KPC-2 by two (P202S and F207L) and a single (F207L) amino acid substitutions, respectively. All three isolates with identical pulsotype belonged to sequence type
Hung-Jen Tang, Y -C Chuang
exaly +3 more sources
Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae-Producing KPC-31, a D179Y Variant of KPC-3. [PDF]
A 68-year-old man had recurrent bacteremia by Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae resistant to ceftazidime-avibactam and cefiderocol.
Cesira Giordano +2 more
exaly +3 more sources
Phenotypic, Biochemical and Genetic Analysis of KPC-41, a KPC-3 Variant Conferring Resistance to Ceftazidime-Avibactam and Exhibiting Reduced Carbapenemase Activity. [PDF]
A novel KPC variant, KPC-41, was identified in a Klebsiella pneumoniae clinical isolate from Switzerland. This β-lactamase possessed a 3-amino-acid insertion (Pro- Asn-Lys) located between amino acids 269 and 270 compared to the KPC-3 amino acid ...
Laurent Poirel +2 more
exaly +2 more sources

